Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC - PubMed (original) (raw)
Review
Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC
G B Frisoni et al. J Neurol Neurosurg Psychiatry. 2003 Oct.
Abstract
Neuroimaging is a mainstay in the differential diagnosis of patients with cognitive impairment. The often equivocal clinical pictures, the prognostic uncertainty of the earliest stages of mild cognitive impairment, and the subtle brain changes mean that neuroimaging techniques are of potentially great incremental diagnostic value. A number of methods, ranging from very simple subjective visual ratings to highly sophisticated computerised tools, have been developed, which allow rating of structural and functional brain changes. The choice of the method is not obvious, and current guidelines provide no indications on which tools should be preferred. In this paper, we give indications for tools with demonstrated accuracy for detecting regional atrophy, cerebrovascular disease, and regional brain function, and discuss these according to increasing technological complexity, ranging from those with high feasibility that can be used at the patient's bedside to highly technological ones that require trained personnel and specific hardware and software.
Similar articles
- Contribution of neuroimaging in the diagnosis of Alzheimer's disease and other dementias.
Scheltens P, Korf ES. Scheltens P, et al. Curr Opin Neurol. 2000 Aug;13(4):391-6. doi: 10.1097/00019052-200008000-00005. Curr Opin Neurol. 2000. PMID: 10970055 Review. - Neuroimaging in cerebrovascular disorders: measurement of cerebral physiology after stroke and assessment of stroke recovery.
Mountz JM, Liu HG, Deutsch G. Mountz JM, et al. Semin Nucl Med. 2003 Jan;33(1):56-76. doi: 10.1053/snuc.2003.127293. Semin Nucl Med. 2003. PMID: 12605357 Review. - Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
Yew B, Nation DA; Alzheimer’s Disease Neuroimaging Initiative. Yew B, et al. Brain. 2017 Jul 1;140(7):1987-2001. doi: 10.1093/brain/awx112. Brain. 2017. PMID: 28575149 Free PMC article. - Measurement of regional cerebral blood flow in humans with single-photon-emitting radioisotopes.
Lassen NA. Lassen NA. Res Publ Assoc Res Nerv Ment Dis. 1985;63:9-20. Res Publ Assoc Res Nerv Ment Dis. 1985. PMID: 3895334 Review. No abstract available. - Single photon emission computed tomography brain imaging.
Mullan BP, O'Connor MK, Hung JC. Mullan BP, et al. Neurosurg Clin N Am. 1996 Oct;7(4):617-51. Neurosurg Clin N Am. 1996. PMID: 8905776 Review.
Cited by
- Volume Analysis of Brain Cognitive Areas in Alzheimer's Disease: Interim 3-Year Results from the ASCOMALVA Trial.
Traini E, Carotenuto A, Fasanaro AM, Amenta F. Traini E, et al. J Alzheimers Dis. 2020;76(1):317-329. doi: 10.3233/JAD-190623. J Alzheimers Dis. 2020. PMID: 32508323 Free PMC article. Clinical Trial. - The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial.
Prins ND, van der Flier WA, Knol DL, Fox NC, Brashear HR, Nye JS, Barkhof F, Scheltens P. Prins ND, et al. Alzheimers Res Ther. 2014 Jul 21;6(4):47. doi: 10.1186/alzrt275. eCollection 2014. Alzheimers Res Ther. 2014. PMID: 25478019 Free PMC article. - Accuracy of dementia diagnosis: a direct comparison between radiologists and a computerized method.
Klöppel S, Stonnington CM, Barnes J, Chen F, Chu C, Good CD, Mader I, Mitchell LA, Patel AC, Roberts CC, Fox NC, Jack CR Jr, Ashburner J, Frackowiak RS. Klöppel S, et al. Brain. 2008 Nov;131(Pt 11):2969-74. doi: 10.1093/brain/awn239. Epub 2008 Oct 3. Brain. 2008. PMID: 18835868 Free PMC article. - Effect of Treatment of the Cholinergic Precursor Choline Alphoscerate in Mild Cognitive Dysfunction: A Randomized Controlled Trial.
Carotenuto A, Andreone V, Amenta F, Traini E. Carotenuto A, et al. Medicina (Kaunas). 2024 Jun 1;60(6):925. doi: 10.3390/medicina60060925. Medicina (Kaunas). 2024. PMID: 38929542 Free PMC article. Clinical Trial. - Hybrid FDG PET/MRI vs. FDG PET and CT in patients with suspected dementia - A comparison of diagnostic yield and propagated influence on clinical diagnosis and patient management.
Kaltoft NS, Marner L, Larsen VA, Hasselbalch SG, Law I, Henriksen OM. Kaltoft NS, et al. PLoS One. 2019 May 2;14(5):e0216409. doi: 10.1371/journal.pone.0216409. eCollection 2019. PLoS One. 2019. PMID: 31048902 Free PMC article. Clinical Trial.
References
- Neurology. 2001 Mar 13;56(5):643-9 - PubMed
- Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3334-9 - PubMed
- Neuroreport. 2001 Mar 26;12(4):851-5 - PubMed
- Neurobiol Aging. 2001 Jul-Aug;22(4):529-39 - PubMed
- AJNR Am J Neuroradiol. 1996 May;17(5):913-23 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical